KERENDIA 10MG (Finerenone (10mg))

Kerendia 10 mg Tablet is indicated for the management of chronic kidney disease (CKD) associated with type 2 diabetes (T2D). This medication acts by inhibiting a specific hormone in the body, which may help to slow the progression of kidney deterioration and lessen the likelihood of cardiovascular events such as heart attacks and heart failure. Patients are advised that Kerendia can be taken with or without food, and it is essential for a healthcare provider to determine the appropriate dosage and duration of treatment. Regular monitoring of various health parameters such as blood pressure, heart rate, electrocardiogram (ECG), estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (UACR), and potassium levels may be necessary until the patient’s condition stabilizes. It is important to continue any other prescribed medications for ongoing management as recommended by the healthcare provider. Patients should inform their doctor if they have any pre-existing kidney or liver conditions and disclose all other medications they are taking. Pregnant and nursing individuals should seek medical advice before starting Kerendia. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.